In July to August 2025, the Charlotte Lozier Institute (CLI) submitted three comments regarding three citizen petitions submitted to the Food and Drug Administration requesting regulatory action on the abortion drug mifepristone. Below, brief summaries and links for each of these comments are provided. CLI Comment on Massachusetts AG et al. Citizen Petition (Submitted 7/24). […]
